{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:59:11Z","timestamp":1784170751103,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2024.217406","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T19:40:10Z","timestamp":1734810010000},"page":"217406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia"],"prefix":"10.1016","volume":"611","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-5435","authenticated-orcid":false,"given":"Maiti\u00fa","family":"\u00d3 Murch\u00fa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5687-3195","authenticated-orcid":false,"given":"Xuehua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-2492","authenticated-orcid":false,"given":"Melissa Anne","family":"Tutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-6345","authenticated-orcid":false,"given":"Ian","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4371-2214","authenticated-orcid":false,"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8659-4943","authenticated-orcid":false,"given":"Niamh","family":"Lynam-Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacintha","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2024.217406_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence\u2010based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"issue":"4","key":"10.1016\/j.canlet.2024.217406_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.217406_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2024.217406_bib4","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/1\/4\/045209","article-title":"A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio","volume":"1","author":"Robert Grimes","year":"2015","journal-title":"Biomedical Physics & Engineering Express"},{"issue":"12","key":"10.1016\/j.canlet.2024.217406_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217406_bib6","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.2147\/IJN.S140462","article-title":"Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment","volume":"13","author":"Graham","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.canlet.2024.217406_bib7","first-page":"1830","article-title":"Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy","volume":"61","author":"Koukourakis","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-022-06609-0","article-title":"Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis","volume":"194","author":"Giatromanolaki","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6560","key":"10.1016\/j.canlet.2024.217406_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.canlet.2024.217406_bib11","first-page":"4200","article-title":"Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions","volume":"57","author":"Kim","year":"1997","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68777-7","article-title":"Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib","volume":"10","author":"Buckley","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2024.217406_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100738","article-title":"Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma","volume":"9","author":"Lynam-Lennon","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.canlet.2024.217406_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.bjc.6690345","article-title":"Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas","volume":"80","author":"Kohshi","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.217406_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0009-9260(78)80081-6","article-title":"Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964--1976","volume":"29","author":"Cade","year":"1978","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.canlet.2024.217406_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fonc.2020.00991","article-title":"Inhibition of oxidative phosphorylation reverses bone marrow hypoxia visualized in imageable syngeneic B-all mouse model","volume":"10","author":"Rytelewski","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2024.217406_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn. Reson. Imaging"},{"issue":"6a","key":"10.1016\/j.canlet.2024.217406_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1667\/RR2295.1","article-title":"Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma","volume":"174","author":"Lynam-Lennon","year":"2010","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217406_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/toxsci\/kfy250","article-title":"Automated morphological feature assessment for zebrafish embryo developmental toxicity screens","volume":"167","author":"Teixid\u00f3","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cga.12142","article-title":"Using zebrafish in systems toxicology for developmental toxicity testing","volume":"56","author":"Nishimura","year":"2016","journal-title":"Congenital. Anom."},{"issue":"7","key":"10.1016\/j.canlet.2024.217406_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.canlet.2024.217406_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"2\u20134","key":"10.1016\/j.canlet.2024.217406_bib23","first-page":"883","article-title":"Preclinical evaluation of Oxygent as an adjunct to radiotherapy","volume":"20","author":"Rockwell","year":"1992","journal-title":"Biomater. Artif. Cells Immobil. Biotechnol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217406_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jvir.2019.04.020","article-title":"Dodecafluoropentane emulsion in acute ischemic stroke: a phase ib\/II randomized and controlled dose-escalation trial","volume":"30","author":"Culp","year":"2019","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217406_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-020-02482-2","article-title":"Perfluorocarbon-based oxygen carriers: from physics to physiology","volume":"473","author":"J\u00e4gers","year":"2021","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217406_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-1139(00)82337-4","article-title":"Perfluorocarbons: chemically inert but biologically active?","volume":"53","author":"Gross","year":"1991","journal-title":"J. Fluor. Chem."},{"issue":"3","key":"10.1016\/j.canlet.2024.217406_bib27","first-page":"132","article-title":"Indocyanine green-loaded perfluorocarbon nanoemulsions for bimodal (19)F-magnetic resonance\/nearinfrared fluorescence imaging and subsequent phototherapy","volume":"3","author":"Wang","year":"2013","journal-title":"Quant. Imag. Med. Surg."},{"issue":"5","key":"10.1016\/j.canlet.2024.217406_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/nano8050283","article-title":"Anti-EGFR indocyanine green-mitomycin C-loaded perfluorocarbon double nanoemulsion: a novel nanostructure for targeted photochemotherapy of bladder cancer cells","volume":"8","author":"Lee","year":"2018","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/j.canlet.2024.217406_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700816","article-title":"Facile synthesis of lipid-perfluorocarbon nanoemulsion coated with silica shell as an ultrasound imaging agent","volume":"7","author":"Yang","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2024.217406_bib30","first-page":"2024","article-title":"Oxygen-releasing nanodroplets relieve intratumoral hypoxia in head and neck cancer spheroids","author":"Xavierselvan","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2024.217406_bib31","series-title":"Color Textbook of Histology E-Book","author":"Gartner","year":"2006"},{"issue":"9","key":"10.1016\/j.canlet.2024.217406_bib32","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s13346-022-01170-1","article-title":"Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity","volume":"12","author":"Tutty","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acs.chemrestox.9b00335","article-title":"Use of zebrafish in drug discovery toxicology","volume":"33","author":"Cassar","year":"2020","journal-title":"Chem. Res. Toxicol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217406_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery","volume":"14","author":"MacRae","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.canlet.2024.217406_bib35","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/cr970143c","article-title":"Oxygen carriers (\u201cblood substitutes\u201d) raison d'\u00eatre, chemistry, and some physiology blut ist ein ganz besondrer saft","volume":"101","author":"Riess","year":"2001","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib36","first-page":"47","article-title":"Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artificial cells, blood substitutes","volume":"33","author":"Riess","year":"2005","journal-title":"Biotechnology"},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib37","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/s41598-021-84076-1","article-title":"Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxygen carriers","volume":"11","author":"Lambert","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-017-3386-2","article-title":"Icorg 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)","volume":"17","author":"Reynolds","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217406_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1166\/jbn.2015.1903","article-title":"Radiosensitization of Hs-766T pancreatic tumor xenografts in mice dosed with dodecafluoropentane nano-emulsion-preliminary findings","volume":"11","author":"Johnson","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"13","key":"10.1016\/j.canlet.2024.217406_bib40","first-page":"3626","article-title":"Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion","volume":"62","author":"Koch","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2024.217406_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00003246-199011000-00008","article-title":"Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients","volume":"18","author":"Spence","year":"1990","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.canlet.2024.217406_bib42","series-title":"Perftoran: History, Clinical Trials, and Pathway Forward","first-page":"361","author":"Latson","year":"2022"},{"issue":"5","key":"10.1016\/j.canlet.2024.217406_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17425247.2021.1856074","article-title":"Loco-regional drug delivery in oncology: current clinical applications and future translational opportunities","volume":"18","author":"Rossi","year":"2021","journal-title":"Expet Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.canlet.2024.217406_bib44","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.21037\/tcr-22-787","article-title":"High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol","volume":"11","author":"Zoa","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217406_bib45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.18632\/oncotarget.13605","article-title":"Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2024.217406_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10735-024-10190-9","article-title":"Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study","volume":"55","author":"Sharaf","year":"2024","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.canlet.2024.217406_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymeth.2017.07.002","article-title":"Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: a systematic review","volume":"130","author":"Peerlings","year":"2017","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.canlet.2024.217406_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clon.2014.01.009","article-title":"Selective targeting of the G2\/M cell cycle checkpoint to improve the therapeutic index of radiotherapy","volume":"26","author":"Dillon","year":"2014","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217406_bib49","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1016\/j.annonc.2023.09.1866","article-title":"680P First results from the phase I trial of the ATR inhibitor, ART0380, in advanced solid tumors","volume":"34","author":"Moore","year":"2023","journal-title":"Ann. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:00:45Z","timestamp":1760742045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524008012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":49,"alternative-id":["S0304383524008012"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217406","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217406"}}